Yixin Wu

miR‐1915 inhibits Bcl‐2 to modulate multidrug resistance by increasing drug‐sensitivity in human colorectal carcinoma cells

Ke Xu, Xin Liang, Daling Cui et al. · Molecular Carcinogenesis · 2011 · 108 citations

Medicine, Cancer Biology, Oncology +17

Surface Modification of Polycaprolactone Scaffold With Improved Biocompatibility and Controlled Growth Factor Release for Enhanced Stem Cell Differentiation

Xiao‐Yan Qin, Yixin Wu, Shuang Liu et al. · Frontiers in Bioengineering and Biotechnology · 2022 · 52 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Bortezomib-resistance is associated with increased levels of proteasome subunits and apoptosis-avoidance

Yixin Wu, Jiahua Yang, Hirotomo Saitsu · Oncotarget · 2016 · 46 citations · Full text

Medicine, Oncology, Pharmacology +16

Apigenin, Chrysin, and Luteolin Selectively Inhibit Chymotrypsin-Like and Trypsin-Like Proteasome Catalytic Activities in Tumor Cells

Yixin Wu, Xin Fang · Planta Medica · 2009 · 33 citations

Life Sciences, Biochemistry, Pharmacology +17

A negatively charged Pt(<scp>iv</scp>) prodrug for electrostatic complexation with polymers to overcome cisplatin resistance

Xiaoxu Kang, Yingjie Yu, Zhigang Chen et al. · Journal of Materials Chemistry B · 2019 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +17